Multiple sclerosis: effect of gamma linolenate administration upon membranes and the need for extended clinical trials of unsaturated fatty acids.
Eur Neurol
; 22(1): 78-83, 1983.
Article
in En
| MEDLINE
| ID: mdl-6301844
ABSTRACT
Electrophoretic mobility studies of red blood cells from subjects with multiple sclerosis indicate that treatment with unsaturated fatty acids must continue for at least 2 years before normal reactivity is restored by currently available tests. If this applies to myelin also, then clinical trials aimed at treating the recognized multiple sclerosis subject by polyunsaturated fatty acids really begin after 2 years, and this should be recognized when a trial program is drawn up.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Linolenic Acids
/
Multiple Sclerosis
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Eur Neurol
Year:
1983
Document type:
Article